The benchmarking platform for drug discovery.
Polaris makes it easy for the machine learning in drug discovery community to share and access datasets & benchmarks.
Increase your impact.
Our aim is to improve the state of benchmarking so ML can have a greater impact on real-world drug discovery scenarios. To start, we hope to provide a single source of truth that aggregates and provides simple access to datasets & benchmarks.
Download a dataset from the Hub
Evaluate your method on a benchmark
Guidelines for dataset curation and method evaluation & comparison.
Starting with small molecules
Through a unique, cross-industry collaboration involving representatives from Recursion Pharmaceuticals, AstraZeneca, Relay Therapeutics, Pfizer, Merck, Nimbus Therapeutics, Blueprint Medicines, Johnson & Johnson, Novartis, Bayer, and Valence Labs, we'll be releasing recommended benchmarks and datasets plus guidelines for dataset curation, method evaluation, and comparison.
Explore Today